Toralgen
Dave Moore has extensive experience in the pharmaceutical industry, having worked at Eli Lilly and Company in various roles from 1993 to 2018. Dave served as a Senior Director in Global Insights and Analytics, where they led a transformation in market research methods and capabilities, among other accomplishments. In 2018, they joined Toralgen as the Chief Operating Officer, focusing on developing pharmaceuticals using a nanoparticle drug delivery platform. Additionally, Dave Moore has worked as an Adjunct Professor at Butler University and as a Partner at Escalate Insights Partners.
Dave Moore holds a Bachelor of Engineering (BE) in Industrial Engineering from Purdue University. Dave also obtained a Master of Business Administration (MBA) with a focus on Business Administration and Management from Indiana University - Kelley School of Business. In addition, Dave has received certifications in NSF I-Corps from the National Science Foundation (NSF) in May 2019, and Principles of Market Research from the University of Georgia in November 2012.
This person is not in any offices
Toralgen
Toralgen is a is a preclinical stage biopharmaceutical company that specializes in the development and commercialization of human therapeutics. They eliminates the challenges of oral delivery in one simple-to-fabricate nanopill. These nanopills also localize the delivery of drug agents and improve the efficacy and safety of therapies.